14,000 Shares in Intuitive Surgical, Inc. $ISRG Purchased by Inspire Trust Co. N.A.

Inspire Trust Co. N.A. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 14,000 shares of the medical equipment provider’s stock, valued at approximately $5,693,000.

Other institutional investors and hedge funds have also modified their holdings of the company. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $27,000. John Boyer Inc. acquired a new position in Intuitive Surgical in the third quarter worth $27,000. Compass Wealth Management LLC acquired a new position in Intuitive Surgical in the third quarter worth $29,000. Main Street Group LTD acquired a new position in Intuitive Surgical in the first quarter worth $30,000. Finally, Compass Financial Management LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 2.3%

Shares of ISRG stock opened at $450.04 on Wednesday. The stock has a 50-day moving average price of $413.15 and a 200 day moving average price of $431.20. The firm has a market cap of $156.00 billion, a price-to-earnings ratio of 54.42, a PEG ratio of 3.17 and a beta of 1.45. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the previous year, the business posted $2.40 EPS. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on ISRG shares. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. Truist Financial cut their price target on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. Oppenheimer reiterated an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Citigroup decreased their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Finally, Robert W. Baird increased their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $493.54.

Insider Activity at Intuitive Surgical

In related news, EVP Mark Brosius sold 61 shares of the stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the transaction, the executive vice president directly owned 581 shares in the company, valued at $256,569.60. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total transaction of $529,000.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at $529,000. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 39,056 shares of company stock worth $17,585,864 over the last 90 days. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.